Qianyong Cao

8PUBLICATIONS
9CO-AUTHORS
Molecular targetsElectrochemical energy storage and conversionNanophotonicsMedical devicesCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 22, 2026
Structure-Based Drug Discovery of Triazine Derivatives as Potent and Orally Bioavailable AXL Inhibitors for Cancer Therapy.

|May 29, 2026
Copper-coordinated dendritic photosensitizer for spatiotemporally synergistic PDT-CDT cascade antitumor therapy.

|Feb 26, 2026
Thionaphthalimide-based photosensitizer for efficient photodynamic therapy.

Qian Chen, Lingyu Jin, Jia Hong

|Oct 10, 2025
A poly(2-ethyl-2-oxazoline)-based AIE-active photosensitizer with aggregation-enhanced reactive oxygen species for efficient photodynamic therapy.

Yuan Wang, Yuqin Xu, Jiawei Gu

|Aug 29, 2025
Structure-based drug discovery of novel penta- or hexa-bicyclo-pyrazolone derivatives as potent and selective AXL inhibitors.

Mingming Sun, Shuang Wu, Ning Xi

|Jun 18, 2025
Development of Cysteic Acid-Modified FAP Radioligands for Enhanced Renal Clearance: From Preclinical Optimization to First-in-Human Study.

Simin Peng, Baoyuan Li, Mingming Sun

Pageof 2

Frequent Collaborators

2 joint publications

Jong Seung Kim

2 joint publications

Xiaoyong Zhang

2 joint publications

Shuang Wu

1 joint publications

Yong Chen